Proton-pump inhibitor use and the risk for community-acquired pneumonia

被引:207
|
作者
Sarkar, Monika [1 ]
Hennessy, Sean [1 ]
Yang, Yu-Xiao [1 ]
机构
[1] Univ Penn, Ctr Clin Epidemiol & Biostat, Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
10.7326/0003-4819-149-6-200809160-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent studies suggest that proton-pump inhibitors (PPIs) may increase the risk for community-acquired pneumonia (CAP). Objective: To examine the association between PPI use and CAP in adults followed in general practices in the United Kingdom. Design: Nested case-control study. Setting: The General Practice Research Database (1987 to 2002) in the United Kingdom. Participants: Patients age 18 years or older with at least 6 months of initial pneumonia-free follow-up in the database. Case patients (n = 80 066) were defined as those who received an incident diagnosis of CAP. Control participants (n = 799 881) were selected by using incidence density sampling, matching on practice site, calendar period, and follow-up duration. Measurements: Use of PPIs within 30 days before the index date. Adjusted odds ratios (ORs) were estimated by using conditional logistic regression, adjusting for potential confounders. Results: Overall, current PPI use was not associated with an increased risk for CAP (adjusted OR, 1.02 [95% CI, 0.97 to 1.08]) or risk for CAP that required hospitalization (adjusted OR, 1.01 [CI, 0.91 to 1.12]). There was a strong increase in risk for CAP associated with current use of PPI therapy that was started within the previous 2 days (adjusted OR, 6.53 [CI, 3.95 to 10.80]), 7 days (adjusted OR, 3.79 [CI, 2.66 to 5.42]), and 14 days (adjusted OR, 3.21 [CI, 2.46 to 4.18]), but there was no statistically significant association for longer-term current PPI therapy. A separate matched case-control analysis, which included the 3 strongest confounders as additional matching factors, yielded similar results as the primary analysis (adjusted OR, 0.96 [CI, 0.91 to 1.02]). Limitations: Adherence to PPI prescription was assumed to be 100%. No radiographic evidence was available to corroborate a diagnosis of CAP. Conclusion: Proton-pump inhibitor therapy started within the past 30 days was associated with an increased risk for CAP, whereas longer-term current use was not.
引用
收藏
页码:391 / W75
页数:10
相关论文
共 50 条
  • [21] Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia
    Roughead, Elizabeth E.
    Ramsay, Emmae N.
    Pratt, Nicole L.
    Ryan, Philip
    Gilbert, Andrew L.
    MEDICAL JOURNAL OF AUSTRALIA, 2009, 190 (03) : 114 - 116
  • [22] Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
    Inghammar, Malin
    Svanstrom, Henrik
    Voldstedlund, Marianne
    Melbye, Mads
    Hviid, Anders
    Molbak, Kare
    Pasternak, Bjorn
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : E1084 - E1089
  • [23] Risk of Community-Acquired Pneumonia in Veteran Patients to Whom Proton Pump Inhibitors Were Dispensed
    Hermos, John A.
    Young, Melissa M.
    Fonda, Jennifer R.
    Gagnon, David R.
    Fiore, Louis D.
    Lawler, Elizabeth V.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (01) : 33 - 42
  • [24] Use of proton pump inhibitors and the risk of community-acquired pneumonia - A population-based case-control study
    Gulmez, Sinem Ezgi
    Holm, Anette
    Frederiksen, Henrik
    Jensen, Thoger Gorm
    Pedersen, Court
    Hallas, Jesper
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (09) : 950 - 955
  • [25] Risk of pneumonia associated with proton pump inhibitor use
    Kenta Watanabe
    Katsunori Iijima
    Journal of Gastroenterology, 2023, 58 : 945 - 946
  • [26] Risk of pneumonia associated with proton pump inhibitor use
    Watanabe, Kenta
    Iijima, Katsunori
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (09) : 945 - 946
  • [27] Reply to: Proton Pump Inhibitors and Long-term Risk of Community-acquired Pneumonia in Older Adults
    Ble, Alessandro
    Zirk-Sadowski, Jan
    Masoli, Jane A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (12) : 2428 - 2429
  • [28] Long-Term Use of Proton Pump Inhibitors and Community-Acquired Pneumonia: Adverse Effect or Bias?
    Ayele, Henok Tadesse
    Dormuth, Colin R.
    Filion, Kristian B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (12) : 2427 - 2428
  • [29] Use of proton-pump inhibitor in hospitalized patients
    Gallego Galisteo, M.
    Guerra Estevez, D.
    Nunez Ortiz, C.
    Villanueva Jimenez, P.
    Villa Rubio, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 582 - 582
  • [30] Proton-pump inhibitor use and the risk of peritoneal dialysis associated peritonitis
    Walia, Nirbaanjot
    Rao, Nisha
    Garrett, Michael
    Yates, Karen
    Malone, Sarah
    Holmes, Christian
    INTERNAL MEDICINE JOURNAL, 2023, 53 (03) : 397 - 403